Filippo Acconcia

Filippo Acconcia

Sep 24, 2017

Group 6 Copy 219
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can hair loss be reversed with Oxy133, a sterol based drug candidate?

Hair loss can affect both men and women, often leaving a negative impact on the affected person’s life...

Can we use our immune cells to fight lung disease?

Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

What's Calcium's role in heart and kidney disease?

Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes...

Campaign Ended